211 related articles for article (PubMed ID: 19159627)
1. Development of a multiplexed fluorescent immunoassay for the quantitation of antibody responses to four Neisseria meningitidis serogroups.
Martins TB; Jaskowski TD; Tebo A; Hill HR
J Immunol Methods; 2009 Mar; 342(1-2):98-105. PubMed ID: 19159627
[TBL] [Abstract][Full Text] [Related]
2. Development of four sandwich ELISAs for quantitation of capsular polysaccharides from Neisseria meningitidis serogroups A, C, W and Y in multivalent vaccines.
Reyes F; Otero O; Cuello M; Amin N; García L; Cardoso D; Camacho F
J Immunol Methods; 2014 May; 407():58-62. PubMed ID: 24727145
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a nonaplex assay for the simultaneous quantitation of antibodies to nine Streptococcus pneumoniae serotypes.
Lal G; Balmer P; Stanford E; Martin S; Warrington R; Borrow R
J Immunol Methods; 2005 Jan; 296(1-2):135-47. PubMed ID: 15680158
[TBL] [Abstract][Full Text] [Related]
4. Development and Evaluation of a Multiplex Microsphere Assay for Quantitation of IgG and IgA Antibodies against Neisseria meningitidis Serogroup A, C, W, and Y Polysaccharides.
Bårnes GK; Kristiansen PA; Caugant DA; Næss LM
Clin Vaccine Immunol; 2015 Jul; 22(7):697-705. PubMed ID: 25924767
[TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of a tetraplex flow cytometric assay for quantitation of serum antibodies to Neisseria meningitidis serogroups A, C, Y, and W-135.
Lal G; Balmer P; Joseph H; Dawson M; Borrow R
Clin Diagn Lab Immunol; 2004 Mar; 11(2):272-9. PubMed ID: 15013975
[TBL] [Abstract][Full Text] [Related]
6. Development and evaluation of a rapid multianalyte particle-based flow cytometric assay for the quantification of meningococcal serogroup B-specific IgM antibodies in sera for nonculture case confirmation.
Laher G; Balmer P; Gray SJ; Dawson M; Kaczmarski EB; Borrow R
FEMS Immunol Med Microbiol; 2006 Oct; 48(1):34-43. PubMed ID: 16965350
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the ontogeny of the murine humoral response to Neisseria meningitidis B capsular polysaccharide reveals levels of complexity relevant to vaccine development.
Colino J; Outschoorn I
J Infect Dis; 2001 Dec; 184(12):1538-47. PubMed ID: 11740729
[TBL] [Abstract][Full Text] [Related]
8. Confirmation of invasive meningococcal disease by single point estimation of IgM antibody to outer membrane protein of Neisseria meningitidis.
Robertson PW; Reinbott P; Duffy Y; Binotto E; Tapsall JW
Pathology; 2001 Aug; 33(3):375-8. PubMed ID: 11523943
[TBL] [Abstract][Full Text] [Related]
9. Avidity of the immunoglobulin G response to a Neisseria meningitidis group C polysaccharide conjugate vaccine as measured by inhibition and chaotropic enzyme-linked immunosorbent assays.
Harris SL; Tsao H; Ashton L; Goldblatt D; Fernsten P
Clin Vaccine Immunol; 2007 Apr; 14(4):397-403. PubMed ID: 17287312
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of the immunogenicity and safety of a new trivalent meningococcal polysaccharide vaccine.
Chandramohan D; Hodgson A; Coleman P; Baiden R; Asante K; Awine E; Owusu-Agyei S; Boutriau D; Nelson CB; Greenwood B
Vaccine; 2007 Sep; 25 Suppl 1():A83-91. PubMed ID: 17521782
[TBL] [Abstract][Full Text] [Related]
11. Meningococcal disease: a review on available vaccines and vaccines in development.
Bröker M; Fantoni S
Minerva Med; 2007 Oct; 98(5):575-89. PubMed ID: 18043565
[TBL] [Abstract][Full Text] [Related]
12. Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005.
Ceyhan M; Yildirim I; Balmer P; Riley C; Laher G; Andrews N; Borrow R; Kurt N; Turgut M; Aydogan A; Ecevit C; Uysal G; Schultze V
Vaccine; 2007 Oct; 25(41):7233-7. PubMed ID: 17707957
[TBL] [Abstract][Full Text] [Related]
13. A novel monoclonal antibody to Neisseria meningitidis serogroup X capsular polysaccharide and its potential use in quantitation of meningococcal vaccines.
Reyes F; Otero O; Camacho F; Amin N; Ramírez F; Valdés Y; Acevedo R; García L; Cardoso D; Cuello M
Biologicals; 2014 Nov; 42(6):312-5. PubMed ID: 25218518
[TBL] [Abstract][Full Text] [Related]
14. Opsonophagocytosis of fluorescent polystyrene beads coupled to Neisseria meningitidis serogroup A, C, Y, or W135 polysaccharide correlates with serum bactericidal activity.
Martinez J; Pilishvili T; Barnard S; Caba J; Spear W; Romero-Steiner S; Carlone GM
Clin Diagn Lab Immunol; 2002 Mar; 9(2):485-8. PubMed ID: 11874898
[TBL] [Abstract][Full Text] [Related]
15. Four monoclonal antibodies against capsular polysaccharides of Neisseria meningitidis serogroups A, C, Y and W135: its application in identity tests.
Reyes F; Amin N; Otero O; Aguilar A; Cuello M; Valdés Y; García LG; Cardoso D; Camacho F
Biologicals; 2013 Jul; 41(4):275-8. PubMed ID: 23791517
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous detection of Haemophilus influenzae type b polysaccharide-specific antibodies and Neisseria meningitidis serogroup A, C, Y, and W-135 polysaccharide-specific antibodies in a fluorescent-bead-based multiplex immunoassay.
de Voer RM; Schepp RM; Versteegh FG; van der Klis FR; Berbers GA
Clin Vaccine Immunol; 2009 Mar; 16(3):433-6. PubMed ID: 19129470
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infants.
Perrett KP; Snape MD; Ford KJ; John TM; Yu LM; Langley JM; McNeil S; Dull PM; Ceddia F; Anemona A; Halperin SA; Dobson S; Pollard AJ
Pediatr Infect Dis J; 2009 Mar; 28(3):186-93. PubMed ID: 19209097
[TBL] [Abstract][Full Text] [Related]
19. Assessment of vaccine potential of the Neisseria-specific protein NMB0938.
Sardiñas G; Climent Y; Rodríguez Y; González S; García D; Cobas K; Caballero E; Pérez Y; Brookes C; Taylor S; Gorringe A; Delgado M; Pajón R; Yero D
Vaccine; 2009 Nov; 27(49):6910-7. PubMed ID: 19751688
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal Antibodies Against the Capsular Polysaccharides A, C, Y, W, and X of Neisseria meningitidis: A Platform for the Quality Control of Meningococcal Vaccines.
González E; Reyes F; Otero O; Camacho F; Cuello M; Ramírez F; Acevedo R
Methods Mol Biol; 2019; 1969():181-203. PubMed ID: 30877678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
